AuntMinnieEurope

Gioele Gatto/Pexels

Spain's radiology society warns CT renewal still far short despite new procurement drive

SERAM's new equipment guide says Spain needs around 80 CT scanners a year. A new government purchasing framework covers 62 over two years, and the MRI and vascular equivalents are still missing.

Featured

Grad-CAM heatmaps showing the AI model's areas of attention overlaid on standard mammography views, as displayed to radiologists during the XAI-assisted reading sessions.

AI can mislead radiologists -- and make the error more persuasive

Valencia became the center of Spanish radiology from 20–23 May as the city hosted SERAM 2026, one of the country's largest medical imaging meetings.

SERAM 2026: AI-assisted triage in deep neck infections

Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).

Image-guided focal laser ablation effective for prostate cancer

June 3, 2026

Sample images from each participant group: A: CT only; B: fused Tc-99m maraciclatide SPECT/CT.

SNMMI: SPECT/CT tracer shows promise in interstitial lung disease

May 31, 2026

SNMMI: Machine-learning model predicts RPT dose

May 30, 2026

Eye movement abnormalities flag brain health risk in ex-racing drivers

May 29, 2026

Check out our Cases of the Week!

68-year-old woman with elevated calcium, parathyroid hormone

A 68-year-old woman presented with elevated ionized calcium level of 6.1 mg/dL and elevated parathyroid hormone (PTH) level of 158 pg/mL.

58-year-old woman with upper arm pain after a fall

38-year-old woman with abdominal pain, missed period

Preablation, postablation, and recurrence multiparametric MRI scans depict a 63-year-old man treated with transperineal focal laser ablation (TPLA) for localized prostate cancer. Clinical parameters included an initial prostate-specific antigen (PSA) level of 7.2 ng/mL, a Prostate Imaging Reporting and Data System (PI-RADS) grade 4 lesion (red circles) in the right apical peripheral zone, and a maximum tumor length of 5 mm. MRI-guided targeted biopsy confirmed a Gleason score 3+4 prostate cancer tumor. (A) Pre-ablation axial T2-weighted MRI scan and apparent diffusion coefficient (ADC) image shows the apical PI-RADS 4 lesion (circles). (B) Six-month post-ablation axial T2-weighted MRI scan and ADC image show cystic necrosis (arrows). There was no evidence of recurrence; the PSA level was 1.5 ng/mL. (C) One-year after ablation, the patient’s PSA level had increased to 4.3 ng/mL. Axial T2-weighted MRI scan and the ADC image shows a recurrent lesion (blue circles) in the right apical peripheral zone adjacent to the ablation scar. Targeted biopsy confirmed Gleason score 3+4 prostate cancer, which was classified as in-field recurrence of clinically significant prostate cancer and subsequently re-treated with TPLA. In summary, serial multiplanar MRI demonstrates treatment response after TPLA with post-ablation necrosis, followed by MRI-detected IFR confirmed with biopsy at 12-month follow-up. Multiparametric MRI was performed with a 3.0-T MRI scanner (Skyra; Siemens Healthineers) using T2-weighted, diffusion-weighted, and ADC sequences, with gadobenate dimeglumine contrast material administration (Bracco Diagnostics).

Image-guided focal laser ablation effective for prostate cancer

Spain's radiology society warns CT renewal still far short despite new procurement drive

SNMMI: SPECT/CT tracer shows promise in interstitial lung disease

SNMMI: Machine-learning model predicts RPT dose

Eye movement abnormalities flag brain health risk in ex-racing drivers

Grad-CAM heatmaps showing the AI model's areas of attention overlaid on standard mammography views, as displayed to radiologists during the XAI-assisted reading sessions.

AI can mislead radiologists -- and make the error more persuasive

SERAM 2026: AI-assisted triage in deep neck infections

RöKo 2026: Nikolaou on AI policy, data gaps, and a prostate cancer paradox

AI model predicts 10-year breast cancer risk

AI devices vary widely in lung cancer detection

Clearance

QT Imaging secures clearance for CT scanner in Saudi Arabia

Curium to invest €32M in French radiopharmaceutical facility

4DMedical acquires contextflow to expand into European lung imaging

Wearable ultrasound patch shows promise for continuous fetal monitoring

NHS spent £1.4B on radiologist shortage fixes in 5 years

QT Imaging secures clearance for CT scanner in Saudi Arabia

By AuntMinnie.com staff writers

The company has now secured regulatory clearance in both Saudi Arabia and the United Arab Emirates.

June 3, 2026

Curium to invest €32M in French radiopharmaceutical facility

By AuntMinnieEurope.com staff writers

The investment will go toward development of a new production line for lutetium-177 PSMA-I&T, a targeted radioligand therapy.

June 1, 2026

France Flag Button 400

4DMedical acquires contextflow to expand into European lung imaging

By AuntMinnie.com staff writers

4DMedical is entering the European market with its acquisition of contextflow.

June 1, 2026

Lung Technology Medicine 400

Video from RöKo 2026: Beckelmann on workforce reform, leadership, and radiology supply

By Claudia Tschabuschnig

Bettina Beckelmann discussed workforce reform, leadership, and radiology supply in a video interview at RöKo 2026.

May 29, 2026

Bettina Beckelmann, Managing Director of Beckelmann GmbH, a Dortmund-based family-owned radiology supplies company.

MMA embolization cuts recurrence risk in chronic subdural hematoma, trials show

By Claudia Tschabuschnig

Adding embolization to subdural hematoma surgery reduces recurrence rates, five randomized trials show.

May 28, 2026

71-year-old patient with headaches and unsteady gait. Coronal MRI before embolization demonstrating a chronic subdural hematoma (cSDH).

Wearable ultrasound patch shows promise for continuous fetal monitoring

By AuntMinnie.com staff writers

The patch uses tracking algorithms to follow the umbilical cord as it moves.

May 28, 2026

A wearable ultrasound patch could provide continuous monitoring of the fetus and umbilical cord during pregnancy.

NHS spent £1.4B on radiologist shortage fixes in 5 years

By AuntMinnieEurope.com staff writers

The RCR said training 10% more clinical radiologists per year would save the NHS £100 million over 10 years.

May 28, 2026

Pound Symbol Arrow Thumb

Health Canada clears latest Hermia molecular imaging update

By AuntMinnie.com staff writers

The clearance allows for Hermia's clinical use across Canadian nuclear medicine and theranostics practices.

May 28, 2026

Am 2014 02 11 15 10 50 886 Canadian Flag 200 (1)

Siemens Healthineers equips Hamburg heart center with imaging

By AuntMinnieEurope.com staff writers

The installation includes 13 angiography systems, a photon-counting CT scanner, a 3-tesla MRI system, and an x-ray imaging station.

May 28, 2026

Cathpax launches Nova-X radiation protection system across EMEA

By AuntMinnieEurope.com staff writers

The system is designed to replace conventional personal protective equipment in interventional neuroradiology settings.

May 28, 2026

GE HealthCare, NordicNeuroLab ink software distribution deal

By AuntMinnie.com staff writers

GE HealthCare will distribute NordicNeuroLab's nordicMEDiVA and nordicAktiva.

May 27, 2026

Jonathan McNulty reappointed editor-in-chief of Radiography

By AuntMinnieEurope.com staff writers

McNulty has been associated with the journal since 2016.

May 27, 2026

Jonathan McNulty, PhD